nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—ALB—acquired immunodeficiency syndrome	0.177	1	CbGaD
Mycophenolate mofetil—UGT1A1—Abacavir—acquired immunodeficiency syndrome	0.0611	0.107	CbGbCtD
Mycophenolate mofetil—UGT2B7—Zidovudine—acquired immunodeficiency syndrome	0.0331	0.0577	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0235	0.041	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.0228	0.0398	CbGbCtD
Mycophenolate mofetil—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0207	0.0361	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.0207	0.036	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.0207	0.036	CbGbCtD
Mycophenolate mofetil—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0181	0.0317	CbGbCtD
Mycophenolate mofetil—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0181	0.0317	CbGbCtD
Mycophenolate mofetil—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0181	0.0316	CbGbCtD
Mycophenolate mofetil—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0164	0.0286	CbGbCtD
Mycophenolate mofetil—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0164	0.0286	CbGbCtD
Mycophenolate mofetil—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0157	0.0274	CbGbCtD
Mycophenolate mofetil—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0135	0.0235	CbGbCtD
Mycophenolate mofetil—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0133	0.0231	CbGbCtD
Mycophenolate mofetil—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0122	0.0212	CbGbCtD
Mycophenolate mofetil—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.012	0.0209	CbGbCtD
Mycophenolate mofetil—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.012	0.0209	CbGbCtD
Mycophenolate mofetil—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0115	0.0201	CbGbCtD
Mycophenolate mofetil—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0115	0.0201	CbGbCtD
Mycophenolate mofetil—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0113	0.0197	CbGbCtD
Mycophenolate mofetil—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0108	0.0189	CbGbCtD
Mycophenolate mofetil—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0104	0.0181	CbGbCtD
Mycophenolate mofetil—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0101	0.0175	CbGbCtD
Mycophenolate mofetil—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00909	0.0159	CbGbCtD
Mycophenolate mofetil—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00909	0.0159	CbGbCtD
Mycophenolate mofetil—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00874	0.0152	CbGbCtD
Mycophenolate mofetil—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00874	0.0152	CbGbCtD
Mycophenolate mofetil—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00863	0.0151	CbGbCtD
Mycophenolate mofetil—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00838	0.0146	CbGbCtD
Mycophenolate mofetil—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00781	0.0136	CbGbCtD
Mycophenolate mofetil—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00674	0.0118	CbGbCtD
Mycophenolate mofetil—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00654	0.0114	CbGbCtD
Mycophenolate mofetil—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00592	0.0103	CbGbCtD
Mycophenolate mofetil—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00592	0.0103	CbGbCtD
Mycophenolate mofetil—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00567	0.00989	CbGbCtD
Mycophenolate mofetil—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0055	0.00959	CbGbCtD
Mycophenolate mofetil—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00517	0.00902	CbGbCtD
Mycophenolate mofetil—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00517	0.00902	CbGbCtD
Mycophenolate mofetil—UGT1A7—blood plasma—acquired immunodeficiency syndrome	0.00496	0.093	CbGeAlD
Mycophenolate mofetil—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00468	0.00816	CbGbCtD
Mycophenolate mofetil—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00468	0.00816	CbGbCtD
Mycophenolate mofetil—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00439	0.00765	CbGbCtD
Mycophenolate mofetil—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00404	0.00704	CbGbCtD
Mycophenolate mofetil—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00392	0.00684	CbGbCtD
Mycophenolate mofetil—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00354	0.00618	CbGbCtD
Mycophenolate mofetil—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00354	0.00618	CbGbCtD
Mycophenolate mofetil—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0034	0.00593	CbGbCtD
Mycophenolate mofetil—UGT1A7—digestive system—acquired immunodeficiency syndrome	0.00191	0.0358	CbGeAlD
Mycophenolate mofetil—UGT1A7—blood—acquired immunodeficiency syndrome	0.00182	0.0341	CbGeAlD
Mycophenolate mofetil—UGT1A10—digestive system—acquired immunodeficiency syndrome	0.00159	0.0299	CbGeAlD
Mycophenolate mofetil—UGT1A6—digestive system—acquired immunodeficiency syndrome	0.00148	0.0278	CbGeAlD
Mycophenolate mofetil—UGT1A1—blood plasma—acquired immunodeficiency syndrome	0.00143	0.0268	CbGeAlD
Mycophenolate mofetil—UGT1A8—digestive system—acquired immunodeficiency syndrome	0.00126	0.0237	CbGeAlD
Mycophenolate mofetil—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.00119	0.0223	CbGeAlD
Mycophenolate mofetil—IMPDH1—retina—acquired immunodeficiency syndrome	0.001	0.0189	CbGeAlD
Mycophenolate mofetil—CES2—retina—acquired immunodeficiency syndrome	0.000919	0.0172	CbGeAlD
Mycophenolate mofetil—IMPDH2—skin of body—acquired immunodeficiency syndrome	0.000887	0.0167	CbGeAlD
Mycophenolate mofetil—CES2—skin of body—acquired immunodeficiency syndrome	0.000807	0.0151	CbGeAlD
Mycophenolate mofetil—UGT1A9—digestive system—acquired immunodeficiency syndrome	0.0008	0.015	CbGeAlD
Mycophenolate mofetil—IMPDH2—lymphoid tissue—acquired immunodeficiency syndrome	0.000719	0.0135	CbGeAlD
Mycophenolate mofetil—IMPDH1—lymphoid tissue—acquired immunodeficiency syndrome	0.000714	0.0134	CbGeAlD
Mycophenolate mofetil—IMPDH2—digestive system—acquired immunodeficiency syndrome	0.00071	0.0133	CbGeAlD
Mycophenolate mofetil—SLCO1B3—vagina—acquired immunodeficiency syndrome	0.000697	0.0131	CbGeAlD
Mycophenolate mofetil—IMPDH2—blood—acquired immunodeficiency syndrome	0.000676	0.0127	CbGeAlD
Mycophenolate mofetil—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000675	0.0127	CbGeAlD
Mycophenolate mofetil—IMPDH1—blood—acquired immunodeficiency syndrome	0.000672	0.0126	CbGeAlD
Mycophenolate mofetil—SLCO1B3—lung—acquired immunodeficiency syndrome	0.000659	0.0124	CbGeAlD
Mycophenolate mofetil—IMPDH2—bone marrow—acquired immunodeficiency syndrome	0.000654	0.0123	CbGeAlD
Mycophenolate mofetil—IMPDH2—spinal cord—acquired immunodeficiency syndrome	0.000652	0.0122	CbGeAlD
Mycophenolate mofetil—IMPDH1—bone marrow—acquired immunodeficiency syndrome	0.00065	0.0122	CbGeAlD
Mycophenolate mofetil—IMPDH1—spinal cord—acquired immunodeficiency syndrome	0.000647	0.0122	CbGeAlD
Mycophenolate mofetil—UGT2B7—digestive system—acquired immunodeficiency syndrome	0.000645	0.0121	CbGeAlD
Mycophenolate mofetil—CES2—digestive system—acquired immunodeficiency syndrome	0.000645	0.0121	CbGeAlD
Mycophenolate mofetil—IMPDH2—vagina—acquired immunodeficiency syndrome	0.000627	0.0118	CbGeAlD
Mycophenolate mofetil—IMPDH1—vagina—acquired immunodeficiency syndrome	0.000623	0.0117	CbGeAlD
Mycophenolate mofetil—CES2—blood—acquired immunodeficiency syndrome	0.000615	0.0115	CbGeAlD
Mycophenolate mofetil—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000609	0.0114	CbGeAlD
Mycophenolate mofetil—CES2—bone marrow—acquired immunodeficiency syndrome	0.000595	0.0112	CbGeAlD
Mycophenolate mofetil—IMPDH2—lung—acquired immunodeficiency syndrome	0.000593	0.0111	CbGeAlD
Mycophenolate mofetil—CES2—spinal cord—acquired immunodeficiency syndrome	0.000592	0.0111	CbGeAlD
Mycophenolate mofetil—IMPDH1—lung—acquired immunodeficiency syndrome	0.000589	0.0111	CbGeAlD
Mycophenolate mofetil—CES2—vagina—acquired immunodeficiency syndrome	0.00057	0.0107	CbGeAlD
Mycophenolate mofetil—IMPDH2—nervous system—acquired immunodeficiency syndrome	0.000549	0.0103	CbGeAlD
Mycophenolate mofetil—UGT1A1—digestive system—acquired immunodeficiency syndrome	0.000549	0.0103	CbGeAlD
Mycophenolate mofetil—IMPDH1—nervous system—acquired immunodeficiency syndrome	0.000546	0.0102	CbGeAlD
Mycophenolate mofetil—CES2—lung—acquired immunodeficiency syndrome	0.000539	0.0101	CbGeAlD
Mycophenolate mofetil—CES1—lymphoid tissue—acquired immunodeficiency syndrome	0.000538	0.0101	CbGeAlD
Mycophenolate mofetil—CES1—digestive system—acquired immunodeficiency syndrome	0.000531	0.00997	CbGeAlD
Mycophenolate mofetil—IMPDH2—central nervous system—acquired immunodeficiency syndrome	0.000529	0.00992	CbGeAlD
Mycophenolate mofetil—IMPDH1—central nervous system—acquired immunodeficiency syndrome	0.000525	0.00986	CbGeAlD
Mycophenolate mofetil—UGT1A1—blood—acquired immunodeficiency syndrome	0.000523	0.00981	CbGeAlD
Mycophenolate mofetil—CES1—blood—acquired immunodeficiency syndrome	0.000506	0.0095	CbGeAlD
Mycophenolate mofetil—CES2—nervous system—acquired immunodeficiency syndrome	0.000499	0.00936	CbGeAlD
Mycophenolate mofetil—CES2—central nervous system—acquired immunodeficiency syndrome	0.00048	0.00902	CbGeAlD
Mycophenolate mofetil—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000457	0.00858	CbGeAlD
Mycophenolate mofetil—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000456	0.00857	CbGeAlD
Mycophenolate mofetil—CES1—lung—acquired immunodeficiency syndrome	0.000444	0.00833	CbGeAlD
Mycophenolate mofetil—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000435	0.00816	CbGeAlD
Mycophenolate mofetil—IMPDH2—brain—acquired immunodeficiency syndrome	0.00042	0.00788	CbGeAlD
Mycophenolate mofetil—IMPDH1—brain—acquired immunodeficiency syndrome	0.000417	0.00783	CbGeAlD
Mycophenolate mofetil—CES1—nervous system—acquired immunodeficiency syndrome	0.000411	0.00771	CbGeAlD
Mycophenolate mofetil—IMPDH2—lymph node—acquired immunodeficiency syndrome	0.000405	0.00761	CbGeAlD
Mycophenolate mofetil—IMPDH1—lymph node—acquired immunodeficiency syndrome	0.000403	0.00756	CbGeAlD
Mycophenolate mofetil—CES1—central nervous system—acquired immunodeficiency syndrome	0.000396	0.00742	CbGeAlD
Mycophenolate mofetil—CES2—brain—acquired immunodeficiency syndrome	0.000381	0.00716	CbGeAlD
Mycophenolate mofetil—CES2—lymph node—acquired immunodeficiency syndrome	0.000369	0.00692	CbGeAlD
Mycophenolate mofetil—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000346	0.00649	CbGeAlD
Mycophenolate mofetil—ABCC2—blood—acquired immunodeficiency syndrome	0.00033	0.00619	CbGeAlD
Mycophenolate mofetil—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000324	0.00607	CbGeAlD
Mycophenolate mofetil—CES1—brain—acquired immunodeficiency syndrome	0.000314	0.00589	CbGeAlD
Mycophenolate mofetil—CES1—lymph node—acquired immunodeficiency syndrome	0.000303	0.0057	CbGeAlD
Mycophenolate mofetil—CYP2C8—blood—acquired immunodeficiency syndrome	0.000247	0.00464	CbGeAlD
Mycophenolate mofetil—ABCG2—blood—acquired immunodeficiency syndrome	0.00024	0.00451	CbGeAlD
Mycophenolate mofetil—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000234	0.0044	CbGeAlD
Mycophenolate mofetil—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000233	0.00437	CbGeAlD
Mycophenolate mofetil—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000232	0.00435	CbGeAlD
Mycophenolate mofetil—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000229	0.0043	CbGeAlD
Mycophenolate mofetil—CYP3A5—blood—acquired immunodeficiency syndrome	0.000223	0.00419	CbGeAlD
Mycophenolate mofetil—ABCG2—vagina—acquired immunodeficiency syndrome	0.000223	0.00418	CbGeAlD
Mycophenolate mofetil—ALB—brain—acquired immunodeficiency syndrome	0.000218	0.0041	CbGeAlD
Mycophenolate mofetil—ALB—lymph node—acquired immunodeficiency syndrome	0.000211	0.00396	CbGeAlD
Mycophenolate mofetil—ABCG2—lung—acquired immunodeficiency syndrome	0.000211	0.00396	CbGeAlD
Mycophenolate mofetil—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000207	0.00388	CbGeAlD
Mycophenolate mofetil—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000198	0.00371	CbGeAlD
Mycophenolate mofetil—CYP3A5—lung—acquired immunodeficiency syndrome	0.000196	0.00367	CbGeAlD
Mycophenolate mofetil—ABCB1—retina—acquired immunodeficiency syndrome	0.000177	0.00333	CbGeAlD
Mycophenolate mofetil—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000176	0.0033	CbGeAlD
Mycophenolate mofetil—CYP3A4—blood—acquired immunodeficiency syndrome	0.000167	0.00314	CbGeAlD
Mycophenolate mofetil—CYP2C8—brain—acquired immunodeficiency syndrome	0.000153	0.00288	CbGeAlD
Mycophenolate mofetil—ABCG2—brain—acquired immunodeficiency syndrome	0.000149	0.0028	CbGeAlD
Mycophenolate mofetil—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000144	0.00271	CbGeAlD
Mycophenolate mofetil—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000136	0.00255	CbGeAlD
Mycophenolate mofetil—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000131	0.00246	CbGeAlD
Mycophenolate mofetil—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000126	0.00236	CbGeAlD
Mycophenolate mofetil—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000124	0.00234	CbGeAlD
Mycophenolate mofetil—ABCB1—blood—acquired immunodeficiency syndrome	0.000119	0.00223	CbGeAlD
Mycophenolate mofetil—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000115	0.00215	CbGeAlD
Mycophenolate mofetil—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000114	0.00214	CbGeAlD
Mycophenolate mofetil—ABCB1—vagina—acquired immunodeficiency syndrome	0.00011	0.00206	CbGeAlD
Mycophenolate mofetil—ABCB1—lung—acquired immunodeficiency syndrome	0.000104	0.00195	CbGeAlD
Mycophenolate mofetil—ABCB1—nervous system—acquired immunodeficiency syndrome	9.62e-05	0.00181	CbGeAlD
Mycophenolate mofetil—ABCB1—central nervous system—acquired immunodeficiency syndrome	9.27e-05	0.00174	CbGeAlD
Mycophenolate mofetil—ABCB1—brain—acquired immunodeficiency syndrome	7.36e-05	0.00138	CbGeAlD
Mycophenolate mofetil—ABCB1—lymph node—acquired immunodeficiency syndrome	7.11e-05	0.00133	CbGeAlD
Mycophenolate mofetil—Myalgia—Ritonavir—acquired immunodeficiency syndrome	5.21e-05	0.000265	CcSEcCtD
Mycophenolate mofetil—Chest pain—Ritonavir—acquired immunodeficiency syndrome	5.21e-05	0.000265	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	5.19e-05	0.000264	CcSEcCtD
Mycophenolate mofetil—Anaemia—Lamivudine—acquired immunodeficiency syndrome	5.19e-05	0.000264	CcSEcCtD
Mycophenolate mofetil—Anxiety—Ritonavir—acquired immunodeficiency syndrome	5.19e-05	0.000264	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	5.17e-05	0.000263	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	5.17e-05	0.000263	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	5.15e-05	0.000262	CcSEcCtD
Mycophenolate mofetil—Pruritus—Abacavir—acquired immunodeficiency syndrome	5.15e-05	0.000262	CcSEcCtD
Mycophenolate mofetil—Anorexia—Delavirdine—acquired immunodeficiency syndrome	5.14e-05	0.000261	CcSEcCtD
Mycophenolate mofetil—Discomfort—Ritonavir—acquired immunodeficiency syndrome	5.14e-05	0.000261	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	5.14e-05	0.000261	CcSEcCtD
Mycophenolate mofetil—Cough—Saquinavir—acquired immunodeficiency syndrome	5.14e-05	0.000261	CcSEcCtD
Mycophenolate mofetil—Angioedema—Lamivudine—acquired immunodeficiency syndrome	5.13e-05	0.000261	CcSEcCtD
Mycophenolate mofetil—Constipation—Indinavir—acquired immunodeficiency syndrome	5.1e-05	0.000259	CcSEcCtD
Mycophenolate mofetil—Pain—Indinavir—acquired immunodeficiency syndrome	5.1e-05	0.000259	CcSEcCtD
Mycophenolate mofetil—Insomnia—Efavirenz—acquired immunodeficiency syndrome	5.1e-05	0.000259	CcSEcCtD
Mycophenolate mofetil—Urticaria—Zidovudine—acquired immunodeficiency syndrome	5.1e-05	0.000259	CcSEcCtD
Mycophenolate mofetil—Convulsion—Saquinavir—acquired immunodeficiency syndrome	5.1e-05	0.000259	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	5.09e-05	0.000259	CcSEcCtD
Mycophenolate mofetil—Hypertension—Saquinavir—acquired immunodeficiency syndrome	5.08e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	5.07e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	5.07e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	5.07e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	5.06e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Malaise—Lamivudine—acquired immunodeficiency syndrome	5.06e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	5.05e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Nausea—Didanosine—acquired immunodeficiency syndrome	5.05e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Vertigo—Lamivudine—acquired immunodeficiency syndrome	5.04e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Hypotension—Delavirdine—acquired immunodeficiency syndrome	5.04e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Syncope—Lamivudine—acquired immunodeficiency syndrome	5.03e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Confusional state—Ritonavir—acquired immunodeficiency syndrome	5.03e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	5.03e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	5.03e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—Somnolence—Efavirenz—acquired immunodeficiency syndrome	5.01e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	5.01e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—Myalgia—Saquinavir—acquired immunodeficiency syndrome	5.01e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—Chest pain—Saquinavir—acquired immunodeficiency syndrome	5.01e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—Anxiety—Saquinavir—acquired immunodeficiency syndrome	4.99e-05	0.000254	CcSEcCtD
Mycophenolate mofetil—Oedema—Ritonavir—acquired immunodeficiency syndrome	4.99e-05	0.000254	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	4.98e-05	0.000253	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	4.98e-05	0.000253	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	4.96e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—Discomfort—Saquinavir—acquired immunodeficiency syndrome	4.95e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	4.93e-05	0.000251	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	4.92e-05	0.00025	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	4.92e-05	0.00025	CcSEcCtD
Mycophenolate mofetil—Shock—Ritonavir—acquired immunodeficiency syndrome	4.91e-05	0.00025	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	4.9e-05	0.000249	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	4.9e-05	0.000249	CcSEcCtD
Mycophenolate mofetil—Cough—Lamivudine—acquired immunodeficiency syndrome	4.9e-05	0.000249	CcSEcCtD
Mycophenolate mofetil—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	4.9e-05	0.000249	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	4.89e-05	0.000249	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	4.89e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—Dizziness—Stavudine—acquired immunodeficiency syndrome	4.88e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	4.88e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—Insomnia—Delavirdine—acquired immunodeficiency syndrome	4.88e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	4.87e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	4.87e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—Convulsion—Lamivudine—acquired immunodeficiency syndrome	4.86e-05	0.000247	CcSEcCtD
Mycophenolate mofetil—Vomiting—Nevirapine—acquired immunodeficiency syndrome	4.86e-05	0.000247	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	4.85e-05	0.000246	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	4.85e-05	0.000246	CcSEcCtD
Mycophenolate mofetil—Confusional state—Saquinavir—acquired immunodeficiency syndrome	4.84e-05	0.000246	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	4.82e-05	0.000245	CcSEcCtD
Mycophenolate mofetil—Pain—Efavirenz—acquired immunodeficiency syndrome	4.82e-05	0.000245	CcSEcCtD
Mycophenolate mofetil—Constipation—Efavirenz—acquired immunodeficiency syndrome	4.82e-05	0.000245	CcSEcCtD
Mycophenolate mofetil—Rash—Nevirapine—acquired immunodeficiency syndrome	4.82e-05	0.000245	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	4.82e-05	0.000245	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	4.81e-05	0.000245	CcSEcCtD
Mycophenolate mofetil—Dizziness—Abacavir—acquired immunodeficiency syndrome	4.81e-05	0.000245	CcSEcCtD
Mycophenolate mofetil—Oedema—Saquinavir—acquired immunodeficiency syndrome	4.8e-05	0.000244	CcSEcCtD
Mycophenolate mofetil—Somnolence—Delavirdine—acquired immunodeficiency syndrome	4.8e-05	0.000244	CcSEcCtD
Mycophenolate mofetil—Headache—Nevirapine—acquired immunodeficiency syndrome	4.79e-05	0.000244	CcSEcCtD
Mycophenolate mofetil—Chest pain—Lamivudine—acquired immunodeficiency syndrome	4.78e-05	0.000243	CcSEcCtD
Mycophenolate mofetil—Myalgia—Lamivudine—acquired immunodeficiency syndrome	4.78e-05	0.000243	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	4.78e-05	0.000243	CcSEcCtD
Mycophenolate mofetil—Infection—Saquinavir—acquired immunodeficiency syndrome	4.77e-05	0.000243	CcSEcCtD
Mycophenolate mofetil—Anxiety—Lamivudine—acquired immunodeficiency syndrome	4.76e-05	0.000242	CcSEcCtD
Mycophenolate mofetil—Anorexia—Ritonavir—acquired immunodeficiency syndrome	4.76e-05	0.000242	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	4.75e-05	0.000241	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	4.75e-05	0.000241	CcSEcCtD
Mycophenolate mofetil—Urticaria—Indinavir—acquired immunodeficiency syndrome	4.74e-05	0.000241	CcSEcCtD
Mycophenolate mofetil—Shock—Saquinavir—acquired immunodeficiency syndrome	4.73e-05	0.00024	CcSEcCtD
Mycophenolate mofetil—Discomfort—Lamivudine—acquired immunodeficiency syndrome	4.72e-05	0.00024	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	4.72e-05	0.00024	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	4.72e-05	0.00024	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	4.71e-05	0.000239	CcSEcCtD
Mycophenolate mofetil—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	4.71e-05	0.000239	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	4.7e-05	0.000239	CcSEcCtD
Mycophenolate mofetil—Vomiting—Stavudine—acquired immunodeficiency syndrome	4.7e-05	0.000239	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	4.69e-05	0.000238	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	4.67e-05	0.000238	CcSEcCtD
Mycophenolate mofetil—Rash—Nelfinavir—acquired immunodeficiency syndrome	4.67e-05	0.000237	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	4.67e-05	0.000237	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	4.67e-05	0.000237	CcSEcCtD
Mycophenolate mofetil—Hypotension—Ritonavir—acquired immunodeficiency syndrome	4.66e-05	0.000237	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	4.66e-05	0.000237	CcSEcCtD
Mycophenolate mofetil—Rash—Stavudine—acquired immunodeficiency syndrome	4.66e-05	0.000237	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Stavudine—acquired immunodeficiency syndrome	4.65e-05	0.000236	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	4.65e-05	0.000236	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	4.64e-05	0.000236	CcSEcCtD
Mycophenolate mofetil—Headache—Nelfinavir—acquired immunodeficiency syndrome	4.64e-05	0.000236	CcSEcCtD
Mycophenolate mofetil—Headache—Stavudine—acquired immunodeficiency syndrome	4.63e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Vomiting—Abacavir—acquired immunodeficiency syndrome	4.63e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Confusional state—Lamivudine—acquired immunodeficiency syndrome	4.62e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Pain—Delavirdine—acquired immunodeficiency syndrome	4.61e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Constipation—Delavirdine—acquired immunodeficiency syndrome	4.61e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	4.61e-05	0.000234	CcSEcCtD
Mycophenolate mofetil—Asthenia—Zidovudine—acquired immunodeficiency syndrome	4.61e-05	0.000234	CcSEcCtD
Mycophenolate mofetil—Rash—Abacavir—acquired immunodeficiency syndrome	4.59e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Abacavir—acquired immunodeficiency syndrome	4.58e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	4.58e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Oedema—Lamivudine—acquired immunodeficiency syndrome	4.58e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Anorexia—Saquinavir—acquired immunodeficiency syndrome	4.58e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Headache—Abacavir—acquired immunodeficiency syndrome	4.56e-05	0.000232	CcSEcCtD
Mycophenolate mofetil—Infection—Lamivudine—acquired immunodeficiency syndrome	4.55e-05	0.000231	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	4.55e-05	0.000231	CcSEcCtD
Mycophenolate mofetil—Nausea—Nevirapine—acquired immunodeficiency syndrome	4.54e-05	0.000231	CcSEcCtD
Mycophenolate mofetil—Pruritus—Zidovudine—acquired immunodeficiency syndrome	4.54e-05	0.000231	CcSEcCtD
Mycophenolate mofetil—Insomnia—Ritonavir—acquired immunodeficiency syndrome	4.51e-05	0.000229	CcSEcCtD
Mycophenolate mofetil—Shock—Lamivudine—acquired immunodeficiency syndrome	4.51e-05	0.000229	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	4.49e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—Hypotension—Saquinavir—acquired immunodeficiency syndrome	4.49e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	4.49e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	4.48e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—Urticaria—Efavirenz—acquired immunodeficiency syndrome	4.48e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	4.46e-05	0.000227	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	4.46e-05	0.000227	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	4.45e-05	0.000226	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	4.45e-05	0.000226	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	4.45e-05	0.000226	CcSEcCtD
Mycophenolate mofetil—Somnolence—Ritonavir—acquired immunodeficiency syndrome	4.44e-05	0.000226	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	4.43e-05	0.000225	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	4.41e-05	0.000224	CcSEcCtD
Mycophenolate mofetil—Nausea—Nelfinavir—acquired immunodeficiency syndrome	4.4e-05	0.000224	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	4.4e-05	0.000224	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	4.39e-05	0.000223	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	4.39e-05	0.000223	CcSEcCtD
Mycophenolate mofetil—Nausea—Stavudine—acquired immunodeficiency syndrome	4.39e-05	0.000223	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	4.38e-05	0.000222	CcSEcCtD
Mycophenolate mofetil—Anorexia—Lamivudine—acquired immunodeficiency syndrome	4.37e-05	0.000222	CcSEcCtD
Mycophenolate mofetil—Insomnia—Saquinavir—acquired immunodeficiency syndrome	4.34e-05	0.000221	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	4.34e-05	0.000221	CcSEcCtD
Mycophenolate mofetil—Nausea—Abacavir—acquired immunodeficiency syndrome	4.32e-05	0.00022	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	4.31e-05	0.000219	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	4.31e-05	0.000219	CcSEcCtD
Mycophenolate mofetil—Urticaria—Delavirdine—acquired immunodeficiency syndrome	4.29e-05	0.000218	CcSEcCtD
Mycophenolate mofetil—Asthenia—Indinavir—acquired immunodeficiency syndrome	4.28e-05	0.000218	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	4.28e-05	0.000218	CcSEcCtD
Mycophenolate mofetil—Hypotension—Lamivudine—acquired immunodeficiency syndrome	4.28e-05	0.000218	CcSEcCtD
Mycophenolate mofetil—Somnolence—Saquinavir—acquired immunodeficiency syndrome	4.27e-05	0.000217	CcSEcCtD
Mycophenolate mofetil—Pain—Ritonavir—acquired immunodeficiency syndrome	4.27e-05	0.000217	CcSEcCtD
Mycophenolate mofetil—Constipation—Ritonavir—acquired immunodeficiency syndrome	4.27e-05	0.000217	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	4.27e-05	0.000217	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	4.27e-05	0.000217	CcSEcCtD
Mycophenolate mofetil—Dizziness—Zidovudine—acquired immunodeficiency syndrome	4.24e-05	0.000216	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	4.23e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Pruritus—Indinavir—acquired immunodeficiency syndrome	4.22e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	4.18e-05	0.000212	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	4.17e-05	0.000212	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	4.16e-05	0.000211	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	4.15e-05	0.000211	CcSEcCtD
Mycophenolate mofetil—Insomnia—Lamivudine—acquired immunodeficiency syndrome	4.14e-05	0.000211	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	4.11e-05	0.000209	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	4.11e-05	0.000209	CcSEcCtD
Mycophenolate mofetil—Constipation—Saquinavir—acquired immunodeficiency syndrome	4.11e-05	0.000209	CcSEcCtD
Mycophenolate mofetil—Pain—Saquinavir—acquired immunodeficiency syndrome	4.11e-05	0.000209	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	4.08e-05	0.000208	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	4.08e-05	0.000208	CcSEcCtD
Mycophenolate mofetil—Vomiting—Zidovudine—acquired immunodeficiency syndrome	4.08e-05	0.000207	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	4.08e-05	0.000207	CcSEcCtD
Mycophenolate mofetil—Somnolence—Lamivudine—acquired immunodeficiency syndrome	4.07e-05	0.000207	CcSEcCtD
Mycophenolate mofetil—Rash—Zidovudine—acquired immunodeficiency syndrome	4.05e-05	0.000206	CcSEcCtD
Mycophenolate mofetil—Asthenia—Efavirenz—acquired immunodeficiency syndrome	4.05e-05	0.000206	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	4.04e-05	0.000206	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	4.03e-05	0.000205	CcSEcCtD
Mycophenolate mofetil—Headache—Zidovudine—acquired immunodeficiency syndrome	4.02e-05	0.000204	CcSEcCtD
Mycophenolate mofetil—Pruritus—Efavirenz—acquired immunodeficiency syndrome	3.99e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	3.98e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	3.98e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—Urticaria—Ritonavir—acquired immunodeficiency syndrome	3.96e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	3.96e-05	0.000201	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	3.96e-05	0.000201	CcSEcCtD
Mycophenolate mofetil—Dizziness—Indinavir—acquired immunodeficiency syndrome	3.95e-05	0.000201	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	3.94e-05	0.000201	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	3.94e-05	0.000201	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	3.93e-05	0.0002	CcSEcCtD
Mycophenolate mofetil—Constipation—Lamivudine—acquired immunodeficiency syndrome	3.92e-05	0.000199	CcSEcCtD
Mycophenolate mofetil—Pain—Lamivudine—acquired immunodeficiency syndrome	3.92e-05	0.000199	CcSEcCtD
Mycophenolate mofetil—Asthenia—Delavirdine—acquired immunodeficiency syndrome	3.87e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	3.86e-05	0.000196	CcSEcCtD
Mycophenolate mofetil—Pruritus—Delavirdine—acquired immunodeficiency syndrome	3.82e-05	0.000194	CcSEcCtD
Mycophenolate mofetil—Urticaria—Saquinavir—acquired immunodeficiency syndrome	3.82e-05	0.000194	CcSEcCtD
Mycophenolate mofetil—Nausea—Zidovudine—acquired immunodeficiency syndrome	3.81e-05	0.000194	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	3.8e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	3.8e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Vomiting—Indinavir—acquired immunodeficiency syndrome	3.8e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	3.78e-05	0.000192	CcSEcCtD
Mycophenolate mofetil—Rash—Indinavir—acquired immunodeficiency syndrome	3.76e-05	0.000191	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Indinavir—acquired immunodeficiency syndrome	3.76e-05	0.000191	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	3.75e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Headache—Indinavir—acquired immunodeficiency syndrome	3.74e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Dizziness—Efavirenz—acquired immunodeficiency syndrome	3.73e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	3.69e-05	0.000188	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	3.68e-05	0.000187	CcSEcCtD
Mycophenolate mofetil—Urticaria—Lamivudine—acquired immunodeficiency syndrome	3.64e-05	0.000185	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	3.62e-05	0.000184	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	3.62e-05	0.000184	CcSEcCtD
Mycophenolate mofetil—Vomiting—Efavirenz—acquired immunodeficiency syndrome	3.59e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—Asthenia—Ritonavir—acquired immunodeficiency syndrome	3.58e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—Dizziness—Delavirdine—acquired immunodeficiency syndrome	3.57e-05	0.000181	CcSEcCtD
Mycophenolate mofetil—Rash—Efavirenz—acquired immunodeficiency syndrome	3.56e-05	0.000181	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	3.55e-05	0.000181	CcSEcCtD
Mycophenolate mofetil—Nausea—Indinavir—acquired immunodeficiency syndrome	3.55e-05	0.00018	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	3.54e-05	0.00018	CcSEcCtD
Mycophenolate mofetil—Headache—Efavirenz—acquired immunodeficiency syndrome	3.53e-05	0.00018	CcSEcCtD
Mycophenolate mofetil—Pruritus—Ritonavir—acquired immunodeficiency syndrome	3.53e-05	0.000179	CcSEcCtD
Mycophenolate mofetil—Asthenia—Saquinavir—acquired immunodeficiency syndrome	3.45e-05	0.000175	CcSEcCtD
Mycophenolate mofetil—Vomiting—Delavirdine—acquired immunodeficiency syndrome	3.43e-05	0.000174	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	3.41e-05	0.000174	CcSEcCtD
Mycophenolate mofetil—Rash—Delavirdine—acquired immunodeficiency syndrome	3.4e-05	0.000173	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	3.4e-05	0.000173	CcSEcCtD
Mycophenolate mofetil—Pruritus—Saquinavir—acquired immunodeficiency syndrome	3.4e-05	0.000173	CcSEcCtD
Mycophenolate mofetil—Headache—Delavirdine—acquired immunodeficiency syndrome	3.38e-05	0.000172	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	3.38e-05	0.000172	CcSEcCtD
Mycophenolate mofetil—Nausea—Efavirenz—acquired immunodeficiency syndrome	3.35e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Dizziness—Ritonavir—acquired immunodeficiency syndrome	3.3e-05	0.000168	CcSEcCtD
Mycophenolate mofetil—Asthenia—Lamivudine—acquired immunodeficiency syndrome	3.29e-05	0.000167	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	3.29e-05	0.000167	CcSEcCtD
Mycophenolate mofetil—Pruritus—Lamivudine—acquired immunodeficiency syndrome	3.24e-05	0.000165	CcSEcCtD
Mycophenolate mofetil—Nausea—Delavirdine—acquired immunodeficiency syndrome	3.21e-05	0.000163	CcSEcCtD
Mycophenolate mofetil—Dizziness—Saquinavir—acquired immunodeficiency syndrome	3.18e-05	0.000161	CcSEcCtD
Mycophenolate mofetil—Vomiting—Ritonavir—acquired immunodeficiency syndrome	3.17e-05	0.000161	CcSEcCtD
Mycophenolate mofetil—Rash—Ritonavir—acquired immunodeficiency syndrome	3.15e-05	0.00016	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	3.14e-05	0.00016	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	3.13e-05	0.000159	CcSEcCtD
Mycophenolate mofetil—Headache—Ritonavir—acquired immunodeficiency syndrome	3.13e-05	0.000159	CcSEcCtD
Mycophenolate mofetil—Vomiting—Saquinavir—acquired immunodeficiency syndrome	3.05e-05	0.000155	CcSEcCtD
Mycophenolate mofetil—Dizziness—Lamivudine—acquired immunodeficiency syndrome	3.03e-05	0.000154	CcSEcCtD
Mycophenolate mofetil—Rash—Saquinavir—acquired immunodeficiency syndrome	3.03e-05	0.000154	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	3.03e-05	0.000154	CcSEcCtD
Mycophenolate mofetil—Headache—Saquinavir—acquired immunodeficiency syndrome	3.01e-05	0.000153	CcSEcCtD
Mycophenolate mofetil—Nausea—Ritonavir—acquired immunodeficiency syndrome	2.96e-05	0.000151	CcSEcCtD
Mycophenolate mofetil—Vomiting—Lamivudine—acquired immunodeficiency syndrome	2.91e-05	0.000148	CcSEcCtD
Mycophenolate mofetil—Rash—Lamivudine—acquired immunodeficiency syndrome	2.89e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	2.89e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—Headache—Lamivudine—acquired immunodeficiency syndrome	2.87e-05	0.000146	CcSEcCtD
Mycophenolate mofetil—Nausea—Saquinavir—acquired immunodeficiency syndrome	2.85e-05	0.000145	CcSEcCtD
Mycophenolate mofetil—Nausea—Lamivudine—acquired immunodeficiency syndrome	2.72e-05	0.000138	CcSEcCtD
